Prevention of Post Sexual Assault Stress
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01430624 |
|
Recruitment Status :
Completed
First Posted : September 8, 2011
Results First Posted : April 13, 2016
Last Update Posted : April 13, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Drug Use Drug Abuse Posttraumatic Stress Disorder | Behavioral: PPRS Behavioral: PIRI | Phase 1 Phase 2 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 245 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Prevention |
| Official Title: | Prevention of Postrape Drug Abuse: Replication Study |
| Study Start Date : | May 2009 |
| Actual Primary Completion Date : | December 2013 |
| Actual Study Completion Date : | December 2013 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: PPRS video
Prevention of post sexual assault stress
|
Behavioral: PPRS
Video including information psychoeducation and modeling of adaptive behavioral coping strategies for use post-assault. Shown at time of post assault medical exam. |
|
Active Comparator: PIRI video
Pleasant imagery and relaxation instruction
|
Behavioral: PIRI
Video containing pleasant imagery and relaxation instruction information. Shown at time of post assault medical exam. |
|
No Intervention: Standard care
Treatment as usual
|
- Drug Abuse Screening Test (DAST-10) [ Time Frame: 6 months ]total possible scores range from 0 - 10 with higher scores indicating poor functioning, post assault at 6 months
- Alcohol Use Disorders Identification Test (AUDIT) [ Time Frame: 6 months ]Total scores range from 0 - 40 with higher scores indicating greater problem severity, post assault at 6 months
- Cigarettes (Estimated Number) [ Time Frame: 14 days preceding 6 week, 3 month and 6 month follow-up ]quantity in 14 days prior to 6 week, 3 month and 6 month follow-up
- Amount of Alcohol Use [ Time Frame: 14 days prior to 6 week, 3 month, 6 month follow-up ]estimated number of drinks during the 14 days prior to each follow-up assessment
- Marijuana Use Frequency [ Time Frame: 14 days prior to 6 week, 3 month, 6 month follow-up ]Number of days of use within the 14 days prior to follow-up assessment
- Any Other Illicit Drug Use [ Time Frame: 14 days prior to 6 week, 3 month, 6 month follow-up ]Any reported use of cocaine or other illicit drugs other than marijuana in the 14 days prior to follow-up
- Non-medical Use of Prescription Drugs Frequency [ Time Frame: 14 days prior to 6 week, 3 month, 6 month follow-up ]Number of days of use within the 14 days prior to follow-up assessment
- PTSD Symptom Scale Self-Report (PSS-SR) [ Time Frame: 2 weeks prior to 6 week, 3 month, 6 month followup ]Total scores range from 0 to 51 with higher scores indicating greater frequency of symptoms, Measure of PTSD symptoms.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 15 Years to 90 Years (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Seeking medical care after recent sexual assault
Exclusion Criteria:
- Active psychosis Active suicidality Cognitive impairment Non-English speaking Severe injury
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01430624
| United States, Minnesota | |
| Hennepin County Medical Center | |
| Minneapolis, Minnesota, United States, 55404 | |
| North Memorial Medical Center | |
| Minneapolis, Minnesota, United States, 55422 | |
| Principal Investigator: | Heidi Resnick, Ph.D. | Medical University of South Carolina |
| Responsible Party: | Medical University of South Carolina |
| ClinicalTrials.gov Identifier: | NCT01430624 |
| Other Study ID Numbers: |
R01DA023099 ( U.S. NIH Grant/Contract ) R01DA023099 ( U.S. NIH Grant/Contract ) |
| First Posted: | September 8, 2011 Key Record Dates |
| Results First Posted: | April 13, 2016 |
| Last Update Posted: | April 13, 2016 |
| Last Verified: | April 2015 |
|
Rape Secondary prevention Intervention |
|
Substance-Related Disorders Stress Disorders, Post-Traumatic Stress Disorders, Traumatic |
Trauma and Stressor Related Disorders Mental Disorders Chemically-Induced Disorders |

